FOLH1 and prostate cancer: All albumin fusions were able to activate T cells when co-incubated with PSMA-expressing cell lines (Fig. 5a–c) and mediate T-cell cytotoxicity against PSMA-expressing prostate cancer cell lines (Fig. 5d–f).